Nu-Med Plus (NUMD) Enterprise Value Growth (1y) (2012 - 2025)
Nu-Med Plus (NUMD) Enterprise Value Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.75 Bn | 194.14 Bn | 7.27 Bn |
| 2 | Stryker | 127.36 Bn | 123.88 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.20 Bn | 72.66 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.77 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 72.14% |
| Sep 30, 2025 | 51.79% |
| Jun 30, 2025 | 78.64% |
| Mar 31, 2025 | 62.67% |
| Dec 31, 2024 | 65.13% |
| Sep 30, 2024 | 63.56% |
| Jun 30, 2024 | 86.51% |
| Mar 31, 2024 | 88.01% |
| Dec 31, 2023 | 90.70% |
| Sep 30, 2023 | -1,665.61% |
| Mar 31, 2023 | -1,990.22% |
| Dec 31, 2022 | -526.94% |
| Sep 30, 2022 | 98.03% |
| Mar 31, 2022 | 98.18% |
| Dec 31, 2021 | 93.81% |
| Sep 30, 2021 | -1.09% |
| Jun 30, 2021 | -1,092.78% |
| Mar 31, 2021 | -659.85% |
| Dec 31, 2020 | -2,562.89% |
| Sep 30, 2020 | 24.71% |